Peptides: Medical Breakthrough or Risky Shortcut? | Dr. Jared Ament & Dr. Jon Kanevsky

Peptides, supplements, GLP-1 weight-loss drugs, NAD, IV drips, and “longevity stacks” are everywhere. But how much do people really know about what they are putting into their bodies? Dr. Jared Ament and Dr. Jon Kanevsky join PragerU CEO Marissa Streit to explain the potential benefits of peptides, why so many Americans are experimenting with them, and why the gray-market peptide industry can be risky. They break down FDA approval, third-party testing, China-based sourcing, growth hormone peptides, Ozempic, retatrutide, creatine, NAD, and the role of AI in helping patients research their own health. They also discuss why good medicine requires both curiosity and humility.

This episode is part of a series of medical interviews. The views expressed by the physicians are their own and do not necessarily reflect the views of the host or PragerU. This episode is for informational purposes only and does not constitute medical advice.

📲 Watch our content ad-free on our app: https://prageru.onelink.me/3bas/vgyxvm79

Your donation to PragerU makes a lasting impact. Give today ➡️ https://l.prageru.com/4jiAT85

Follow PragerU:
Instagram ➡️ (https://www.instagram.com/prageru/)
X ➡️ (https://twitter.com/prageru)
Facebook ➡️ (https://www.facebook.com/prageru/)
TikTok ➡️ (https://www.tiktok.com/@prageru)

Follow Marissa:
Instagram ➡️ (https://www.instagram.com/marissastreit/)
X ➡️ (https://twitter.com/marissastreit)
LinkedIn ➡️ (https://www.linkedin.com/in/marissastreit/)
YouTube ➡️ (https://www.youtube.com/@realtalkwithmarissa)